Related Experiment Video
Updated: Jun 6, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Infant botulism in Australia: availability of human botulinum antitoxin for treatment
Meryta L A May1, Michael A Corkeron, Mark Stretton
1Paediatric Infection Management Service, Mater Children's Hospital, Brisbane, QLD, Australia. meryta.may@mater.org.au
Abstract:
We report the first Australian case of treatment of infant botulism with a human botulinum antitoxin developed in the United States by the California Department of Public Health. Our patient's clinical improvement was rapid, and although the product is expensive, cost-analysis supports the economical viability of its use. In future cases of suspected infant botulism, we recommend that Australian clinicians promptly obtain and administer this antitoxin to their patient.
More Related Videos
Related Concept Videos
Botulism
Diphtheria
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Tetanus

